Leading climate investors are backing Modern Synthesis’ biomaterial technology to reduce emissions and plastic pollution from fashion, footwear, and automotive industries. LONDON, UK. February 5th, 2025 – Modern Synthesis, a biotechnology company pioneering the development of microbially-derived biomaterials, today announces the successful close of a $5.5 million funding round. The
BOSTON, MA, USA. May 13th, 2024 – eLabNext, an Eppendorf Group Company and leading provider of Digital Lab Platforms that include lab inventory management systems (LIMS), electronic lab notebooks (ELN), and artificial intelligence (AI)/machine learning (ML) solutions for life science laboratories, has joined forces with Zifo, a distinguished scientific informatics
CORK, IRELAND, March 05, 2024 – Applied Biopharm Consulting Ltd has been awarded a grant from the Local Enterprise Office Cork North and West to fund a feasibility study, as part of an office-based assessment, to engineer viral capsids and other molecules using artificial intelligence and advanced computational tools. The
Pioneering US Startup focused on longevity supplementation establishes Local UK presence LONDON, UK. 12th January 2024 – In a significant stride towards global expansion, Perpetua Life Biotech, a U.S.-based startup specialising in gerontology and longevity medicine, proudly announces the establishment of Perpetua Life Biotech UK Ltd. The newly formed UK